Viral Hepatitis Alerts—A CME/CE/CPE-Certified Webinar Series

A series of live Webinars in which expert faculty review key data and provide perspectives on emerging developments in the care of patients with viral hepatitis.
Jordan J. Feld, MD, MPH
Paul Y. Kwo, MD
Nancy Reau, MD, FAASLD, AGAF
Norah Terrault, MD, MPH
Stefan Zeuzem, MD

Downloadable Slidesets

In this downloadable slideset, Jordan J. Feld, MD, MPH, Nancy Reau, MD, FAASLD, AGAF, and Stefan Zeuzem, MD, review how recently-approved DAA regimens fit into the current therapeutic landscape for treatment-naive patients with HCV.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: November 2, 2017

In this downloadable slideset, Jordan J. Feld, MD, MPH, Nancy Reau, MD, FAASLD, AGAF, and Stefan Zeuzem, MD, review how recently-approved DAA regimens fit into the current therapeutic landscape for treatment-experienced patients with HCV.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: November 2, 2017

In this downloadable slideset, Norah Terrault, MD, MPH, and Stacey Trooskin, MD, PhD, review important strategies for closing gaps along the HCV care continuum with a focus on overcoming barriers to reach and treat persons who inject drugs.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: December 19, 2017

In this downloadable slideset, Ira M. Jacobson, MD, and Paul Y. Kwo, MD, review optimal management of patients with HCV who have achieved SVR, including recommendations for HCV RNA and HCC monitoring.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: February 6, 2018

In this downloadable slideset, Robert S. Brown, Jr., MD, MPH, and Norah Terrault, MD, MPH, review important 2018 updates to expert HBV guidance recommendations and how these changes affect clinical practice.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: March 6, 2018

Downloadable Audio

Listen to downloadable audio from a series of live Webinars by Jordan J. Feld, MD, MPH; Nancy Reau, MD, FAASLD, AGAF; and Stefan Zeuzem, MD, in which the impact of recently approved direct-acting antiviral regimens for treatment-naive patients with HCV is discussed.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: November 15, 2017

Listen to downloadable audio from a series of live Webinars by Jordan J. Feld, MD, MPH; Nancy Reau, MD, FAASLD, AGAF; and Stefan Zeuzem, MD, in which the impact of recently approved direct-acting antiviral regimens for treatment-experienced patients with HCV is discussed.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: November 16, 2017

Listen to downloadable audio from a series of live Webinars in which expert faculty review important strategies for closing gaps along the HCV care continuum with a focus on overcoming barriers to reach and treat persons who inject drugs.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: January 2, 2018

Listen to downloadable audio from a series of live Webinars by Ira M. Jacobson, MD, and Paul Y. Kwo, MD, in which the optimal management of patients with HCV who have achieved SVR is discussed and audience questions are answered.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: February 14, 2018

Listen to downloadable audio from a series of live Webinars by Robert S. Brown, Jr., MD, MPH, and Norah Terrault, MD, MPH, in which the impact of 2018 updates to expert HBV guidance recommendations is discussed and audience questions are answered.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: April 26, 2018

ClinicalThought

What parameters now qualify a patient infected with HCV for shortened first-line therapy?

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: November 15, 2017

With the approvals of SOF/VEL/VOX and GLE/PIB, what is the new management approach for DAA-experienced patients with HCV infection?

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: November 16, 2017

Here’s my take on why colocalization of HCV treatment with other medical and social services may be ideal for persons who inject drugs.

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Norah Terrault, MD, MPH Stefan Zeuzem, MD Released: January 3, 2018

Which patients, who have achieved a sustained virologic response with HCV treatment, need to be screened for hepatocellular carcinoma? Here’s my approach.

Jordan J. Feld, MD, MPH Paul Y. Kwo, MD Nancy Reau, MD, FAASLD, AGAF Stefan Zeuzem, MD Released: February 14, 2018

Following recent updates to the AASLD HBV guidelines, what criteria determine optimal therapy for immune-active CHB?

Jordan J. Feld, MD, MPH Nancy Reau, MD, FAASLD, AGAF Norah Terrault, MD, MPH Stefan Zeuzem, MD Released: April 30, 2018

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?